McKesson Profit Margin 2006-2018 | MCK

Current and historical gross margin, operating margin and net profit margin for McKesson (MCK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. McKesson net profit margin as of December 31, 2018 is -0.15%.
McKesson Annual Profit Margins
McKesson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.123B $208.357B
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by their ICARE shared principles, their employees work every day to innovate and deliver opportunities that make their customers and partners more successful - all for the better health of patients.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.557B 20.78
Align Technology (ALGN) United States $23.765B 64.16
AmerisourceBergen (ABC) United States $15.640B 11.35
Laboratory Of America Holdings (LH) United States $15.193B 13.97
Cooper (COO) United States $13.946B 24.33
Cardinal Health (CAH) United States $13.882B 9.35
DENTSPLY SIRONA (XRAY) United States $11.277B 25.08
Henry Schein (HSIC) United States $9.593B 15.50
West Pharmaceutical Services (WST) United States $8.495B 41.00
Merit Medical Systems (MMSI) United States $3.106B 32.29
CONMED (CNMD) United States $2.259B 36.04
Patterson (PDCO) United States $2.062B 16.29
Atrion (ATRI) United States $1.631B 47.87
STAAR Surgical (STAA) United States $1.380B 115.63
Antares Pharma (ATRS) United States $0.443B 0.00
Invacare (IVC) United States $0.247B 0.00
Lifevantage (LFVN) United States $0.169B 22.79
Pro-Dex (PDEX) United States $0.067B 30.66
Endologix (ELGX) United States $0.061B 0.00
Biolase (BIOL) United States $0.046B 0.00
Retractable Technologies (RVP) United States $0.023B 0.00
Milestone Scientific (MLSS) United States $0.018B 0.00